MEDIROM Healthcare Technologies Stock-Based Compensation 2021-2024 | MRM

MEDIROM Healthcare Technologies stock-based compensation from 2021 to 2024. Stock-based compensation can be defined as the estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors
MEDIROM Healthcare Technologies Annual Stock-Based Compensation
(Millions of US $)
2024 $N/A
2023 $N/A
2022 $N/A
2021 $2
2020 $N/A
2019 $N/A
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.005B $0.055B
MEDIROM Healthcare Technologies Inc. is a holistic healthcare company. MEDIROM Healthcare Technologies Inc. is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.637B 19.35
Encompass Health (EHC) United States $11.786B 24.99
DaVita (DVA) United States $11.101B 15.33
Chemed (CHE) United States $8.326B 26.17
Elanco Animal Health (ELAN) United States $6.367B 13.64
Option Care Health (OPCH) United States $5.217B 23.25
RadNet (RDNT) United States $4.278B 271.57
Amedisys (AMED) United States $3.132B 21.06
LifeStance Health (LFST) United States $2.275B 0.00
Addus HomeCare (ADUS) United States $2.034B 22.33
Astrana Health (ASTH) United States $1.600B 39.64
U.S Physical Therapy (USPH) United States $1.175B 30.33
Aveanna Healthcare Holdings (AVAH) United States $1.128B 64.22
Pennant (PNTG) United States $1.019B 37.40
Atai Life Sciences (ATAI) Germany $0.288B 0.00
Daxor (DXR) United States $0.035B 0.00
Ontrak (OTRK) United States $0.007B 0.00
Psychemedics (PMD) United States $0.000B 0.00